Asthma and COVID-19 risk: a systematic review and meta-analysis
Background Individual case series and cohort studies have reported conflicting results in
people with asthma on the vulnerability to and risk of mortality from coronavirus disease …
people with asthma on the vulnerability to and risk of mortality from coronavirus disease …
[HTML][HTML] Chronic diseases as a predictor for severity and mortality of COVID-19: a systematic review with cumulative meta-analysis
JS Geng, XL Yu, HN Bao, Z Feng, XY Yuan… - Frontiers in …, 2021 - frontiersin.org
Introduction: Given the ongoing coronavirus disease 2019 (COVID-19) pandemic and the
consequent global healthcare crisis, there is an urgent need to better understand risk factors …
consequent global healthcare crisis, there is an urgent need to better understand risk factors …
Asthma in adult patients with COVID-19. Prevalence and risk of severe disease
Rationale: Health outcomes of people with coronavirus disease (COVID-19) range from no
symptoms to severe illness and death. Asthma, a common chronic lung disease, has been …
symptoms to severe illness and death. Asthma, a common chronic lung disease, has been …
Longitudinal plasma proteomics analysis reveals novel candidate biomarkers in acute COVID-19
Y Mohammed, DR Goodlett, MP Cheng… - Journal of proteome …, 2022 - ACS Publications
The host response to COVID-19 pathophysiology over the first few days of infection remains
largely unclear, especially the mechanisms in the blood compartment. We report on a …
largely unclear, especially the mechanisms in the blood compartment. We report on a …
[HTML][HTML] Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis
A Zinellu, AA Mangoni - Journal of nephrology, 2022 - Springer
Background Combined markers of renal dysfunction and inflammation, eg, cystatin C, might
assist with risk stratification and clinical decisions in patients with coronavirus disease 19 …
assist with risk stratification and clinical decisions in patients with coronavirus disease 19 …
[HTML][HTML] Prognostic performance of cystatin C in COVID-19: a systematic review and meta-analysis
M Matuszewski, Y Reznikov, M Pruc… - International Journal of …, 2022 - mdpi.com
Cystatin C is a specific biomarker of kidney function. We perform this meta-analysis to
determine the association of Cystatin C with the COVID-19 severity. In this systematic review …
determine the association of Cystatin C with the COVID-19 severity. In this systematic review …
[HTML][HTML] Role of cystatin C and calprotectin as potential early prognostic biomarkers in COVID-19 patients admitted to a dedicated COVID care facility
Background: The COVID-19 pandemic has claimed millions of lives. A tool for early
prediction of severity and mortality risk is desirable for better utilization of health care …
prediction of severity and mortality risk is desirable for better utilization of health care …
Impact of asthma on severity and outcomes in COVID-19
BACKGROUND: We conducted this systematic review to evaluate whether asthma
increases the risk of severe disease and adverse outcomes among subjects with COVID-19 …
increases the risk of severe disease and adverse outcomes among subjects with COVID-19 …
[HTML][HTML] Serum hydroxybutyrate dehydrogenase and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression
Alterations in cardiac and renal biomarkers have been reported in coronavirus disease 19
(COVID-19). We conducted a systematic review and meta-analysis to investigate serum …
(COVID-19). We conducted a systematic review and meta-analysis to investigate serum …
[HTML][HTML] Heterogeneity and risk of bias in studies examining risk factors for severe illness and death in COVID-19: a systematic review and meta-analysis
This systematic review and meta-analysis synthesized the evidence on the impacts of
demographics and comorbidities on the clinical outcomes of COVID-19, as well as the …
demographics and comorbidities on the clinical outcomes of COVID-19, as well as the …